{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:33:24Z","timestamp":1784907204998,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY1271"],"award-info":[{"award-number":["2024KY1271"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY322"],"award-info":[{"award-number":["2025KY322"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115848","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:40:30Z","timestamp":1763638830000},"page":"115848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Isolinderalactone attenuates atherosclerosis through inhibiting NF-\u03baB-mediated inflammation in macrophages"],"prefix":"10.1016","volume":"168","author":[{"given":"Yudie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsha","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mincong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2025.115848_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/biom8030080","article-title":"Research Progress on the relationship between atherosclerosis and inflammation","volume":"8","author":"Zhu","year":"2018","journal-title":"Biomolecules"},{"issue":"8 Suppl","key":"10.1016\/j.intimp.2025.115848_bb0010","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115848_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"10","key":"10.1016\/j.intimp.2025.115848_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0025","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41569-019-0265-3","article-title":"Transcriptional and epigenetic regulation of macrophages in atherosclerosis","volume":"17","author":"Kuznetsova","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"239","key":"10.1016\/j.intimp.2025.115848_bb0030","doi-asserted-by":"crossref","first-page":"239ps2","DOI":"10.1126\/scitranslmed.3008922","article-title":"Atherosclerosis--multiple pathways to lesional macrophages","volume":"6","author":"Schulz","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.115848_bb0035","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med. (Berl)"},{"issue":"8","key":"10.1016\/j.intimp.2025.115848_bb0040","article-title":"Oxidized LDLs as signaling molecules","volume":"10","author":"Zingg","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"7855","key":"10.1016\/j.intimp.2025.115848_bb0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2025.115848_bb0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2025.115848_bb0055","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115848_bb0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/eurheartj\/ehl445","article-title":"A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis","volume":"28","author":"Patel","year":"2007","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.intimp.2025.115848_bb0065","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting","volume":"135","author":"Natarajan","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.intimp.2025.115848_bb0070","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41569-023-00854-6","article-title":"Current concepts and novel targets for antiplatelet therapy","volume":"20","author":"Gawaz","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0075","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jvs.2014.07.006","article-title":"Antiplatelet therapy before, during, and after extremity revascularization","volume":"60","author":"Yang","year":"2014","journal-title":"J. Vasc. Surg."},{"issue":"14","key":"10.1016\/j.intimp.2025.115848_bb0080","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2023.02.007","article-title":"Combination moderate-intensity statin and ezetimibe therapy for elderly patients with atherosclerosis","volume":"81","author":"Lee","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115848_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"Pt A","key":"10.1016\/j.intimp.2025.115848_bb0090","article-title":"Traditional uses, phytochemistry, pharmacology, processing methods and quality control of Lindera aggregata (Sims) Kosterm: A critical review","volume":"318","author":"Tao","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115848_bb0095","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1021\/np900354q","article-title":"Sesquiterpene lactones from the root tubers of Lindera aggregata","volume":"72","author":"Gan","year":"2009","journal-title":"J. Nat. Prod."},{"issue":"9","key":"10.1016\/j.intimp.2025.115848_bb0100","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1248\/cpb.55.1390","article-title":"A new sesquiterpene isolated from Lindera aggregata (SIMS) KOSTERM","volume":"55","author":"Cheng","year":"2007","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"48","key":"10.1016\/j.intimp.2025.115848_bb0105","doi-asserted-by":"crossref","first-page":"36101","DOI":"10.1039\/D4RA05643D","article-title":"Characterization and quantification of the phytochemical constituents and anti-inflammatory properties of Lindera aggregata","volume":"14","author":"Wen","year":"2024","journal-title":"RSC Adv."},{"issue":"Pt B","key":"10.1016\/j.intimp.2025.115848_bb0110","article-title":"A natural sesquiterpene lactone isolinderalactone attenuates lipopolysaccharide-induced inflammatory response and acute lung injury through inhibition of NF-kappaB pathway and activation Nrf2 pathway in macrophages","volume":"124","author":"Shen","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115848_bb0115","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2174\/1871520623666230112165440","article-title":"Isolinderalactone resistance to the liver injury induced by Oxaliplatin in rats through inhibiting IL-6\/STAT3 signal pathway","volume":"23","author":"Lin","year":"2023","journal-title":"Anticancer Agents Med Chem."},{"issue":"18","key":"10.1016\/j.intimp.2025.115848_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814246","article-title":"Isolinderalactone induces apoptosis, autophagy, cell cycle arrest and MAPK activation through ROS-mediated signaling in colorectal Cancer cell lines","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115848_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154383","article-title":"Isolinderalactone sensitizes oxaliplatin-resistance colorectal cancer cells through JNK\/p38 MAPK signaling pathways","volume":"105","author":"Kwak","year":"2022","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.intimp.2025.115848_bb0130","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3892\/mmr.2014.2015","article-title":"Isolinderalactone inhibits proliferation of A549 human non-small cell lung cancer cells by arresting the cell cycle at the G0\/G1 phase and inducing a Fas receptor and soluble Fas ligand-mediated apoptotic pathway","volume":"9","author":"Chang","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2025.115848_bb0135","first-page":"566","article-title":"Linderalactone inhibits human lung cancer growth by modulating the expression of apoptosis-related proteins, G2\/M cell cycle arrest and inhibition of JAK\/STAT signalling pathway","volume":"24","author":"Deng","year":"2019","journal-title":"J. B.U.ON."},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0140","first-page":"4690","article-title":"Anti-metastatic effects of isolinderalactone via the inhibition of MMP-2 and up regulation of NM23-H1 expression in human lung cancer A549 cells","volume":"15","author":"Chuang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.intimp.2025.115848_bb0145","article-title":"Linderalactone suppresses pancreatic Cancer development in vitro and in vivo via negatively regulating PI3K\/AKT signaling pathway","volume":"2022","author":"Xu","year":"2022","journal-title":"J. Oncol."},{"issue":"20","key":"10.1016\/j.intimp.2025.115848_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207530","article-title":"Isolinderalactone induces cell death via mitochondrial superoxide- and STAT3-mediated pathways in human ovarian Cancer cells","volume":"21","author":"Rajina","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3892\/ol.2022.13448","article-title":"Isolinderalactone inhibits glioblastoma cell supernatant-induced angiogenesis","volume":"24","author":"Lee","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.intimp.2025.115848_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2020.03.009","article-title":"Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models","volume":"478","author":"Park","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.115848_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2018.11.027","article-title":"Isolinderalactone regulates the BCL-2\/caspase-3\/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model","volume":"443","author":"Hwang","year":"2019","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.intimp.2025.115848_bb0170","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3892\/or.2015.4503","article-title":"Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancer","volume":"35","author":"Yen","year":"2016","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2025.115848_bb0175","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1021\/acs.jnatprod.3c00894","article-title":"Isolinderalactone ameliorates the pathology of Alzheimer\u2019s disease by inhibiting the JNK signaling pathway","volume":"86","author":"Xiong","year":"2023","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.intimp.2025.115848_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102706","article-title":"Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis","volume":"53","author":"Chen","year":"2020","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.intimp.2025.115848_bb0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115848_bb0190","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","article-title":"Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?","volume":"19","author":"Engelen","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"6917","key":"10.1016\/j.intimp.2025.115848_bb0195","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2025.115848_bb0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2025.115848_bb0205","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.intimp.2025.115848_bb0210","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molmed.2003.10.007","article-title":"Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis","volume":"9","author":"Kutuk","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2025.115848_bb0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.11.015","article-title":"Saturated fatty acids trigger TLR4-mediated inflammatory response","volume":"244","author":"Rocha","year":"2016","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.intimp.2025.115848_bb0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115848_bb0225","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tips.2013.09.008","article-title":"Toll-like receptors in atherosclerosis: a \u2018Pandora\u2019s box\u2019 of advances and controversies","volume":"34","author":"Cole","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115848_bb0230","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115848_bb0235","first-page":"250","article-title":"ROS-induced endothelial dysfunction in the pathogenesis of atherosclerosis","volume":"16","author":"Yan","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.intimp.2025.115848_bb0240","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2019.10.011","article-title":"Role of reactive oxygen species in atherosclerosis: lessons from murine genetic models","volume":"149","author":"Negre-Salvayre","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115848_bb0245","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11926-012-0313-z","article-title":"Cholesterol crystals and inflammation","volume":"15","author":"Grebe","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"issue":"18","key":"10.1016\/j.intimp.2025.115848_bb0250","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1093\/eurheartj\/ehq107","article-title":"SIRT1 decreases lox-1-mediated foam cell formation in atherogenesis","volume":"31","author":"Stein","year":"2010","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0255","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jacc.2006.09.034","article-title":"CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans","volume":"49","author":"Lehrke","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115848_bb0260","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood-2003-05-1450","article-title":"Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype","volume":"103","author":"Kanters","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0265","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1124\/pr.118.017178","article-title":"Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products","volume":"71","author":"Wang","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2025.115848_bb0270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41569-024-01100-3","article-title":"Cholesterol crystals in the pathogenesis of atherosclerosis","volume":"22","author":"Baumer","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"issue":"25","key":"10.1016\/j.intimp.2025.115848_bb0275","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/eurheartj\/ehv653","article-title":"Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque","volume":"37","author":"Janoudi","year":"2016","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.intimp.2025.115848_bb0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115848_bb0285","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","article-title":"Update on acute coronary syndromes: the pathologists\u2019 view","volume":"34","author":"Falk","year":"2013","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.intimp.2025.115848_bb0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00395-023-01023-z","article-title":"Macrophage profiling in atherosclerosis: understanding the unstable plaque","volume":"119","author":"Gianopoulos","year":"2024","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0295","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","article-title":"Macrophage phenotype and function in different stages of atherosclerosis","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ. Res."},{"issue":"23","key":"10.1016\/j.intimp.2025.115848_bb0300","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Leducq transatlantic network on, inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.intimp.2025.115848_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015160","article-title":"New Dawn for atherosclerosis: vascular endothelial cell senescence and death","volume":"24","author":"Bu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0310","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"issue":"21","key":"10.1016\/j.intimp.2025.115848_bb0315","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/CIRCULATIONAHA.120.049922","article-title":"Fate and state of vascular smooth muscle cells in atherosclerosis","volume":"143","author":"Miano","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0320","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115848_bb0325","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/cvr\/cvy022","article-title":"Smooth muscle cell fate and plasticity in atherosclerosis","volume":"114","author":"Allahverdian","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"43","key":"10.1016\/j.intimp.2025.115848_bb0330","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1093\/eurheartj\/ehac097","article-title":"The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-kappaB pathway","volume":"43","author":"Farina","year":"2022","journal-title":"Eur. Heart J."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:15:54Z","timestamp":1766153754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925018363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":66,"alternative-id":["S1567576925018363"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115848","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolinderalactone attenuates atherosclerosis through inhibiting NF-\u03baB-mediated inflammation in macrophages","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115848"}}